The 2020s tested resilience worldwide, as the COVID-19 pandemic, remote work, and rapid digital change reshaped daily life. In Puerto Rico, Lilly’s people continued to drive innovation, launching breakthrough medicines and advancing projects that modernized insulin and renewed trusted therapies. As facilities shifted with the opening of new spaces like PC50, community ties deepened through education, volunteerism, and partnerships. With Project Cordillera on the horizon, the future holds new opportunities as Lilly’s impact will continue to shape Puerto Rico for decades to come.